cGMP xeno-free human umbilical cord-derived MSCs to support allogenic therapeutic cell manufacturing.
Leverage a consistent and reliable supply of our high volume, well-characterized, and standardized WCBs (working cell banks) for your large scale allogeneic cell manufacturing – and bypass major steps and risk-points in cGMP MSC production. With a rapid 2D process to generate Billions of MSCs, CliniControl™ hMSCs and expansion media get you to the clinic faster, and then scale with your clinical progression to meet your lot size requirements.
Starting with donor tissue sourced under strict guidelines, CliniControl™ (CC) human umbilical cord-derived hMSCs, isolated from the perivascular Wharton’s Jelly region of the UC, are manufactured with methods and controls that conform with current Good Manufacturing Practices (cGMP).
To further accelerate your translational research, this clinically-relevant WCB can be tested in development prior to cGMP manufacturing.
Intended Use: For Further Manufacturing Use Only. Not intended for diagnostic use or for direct human or veterinary therapeutic use.
Login to search Certificates of Analysis and Quality Control Briefs.